Dentsply Sirona Inc. Faces Legal Action Over Misleading Claims
Dentsply Sirona Inc. (NASDAQ: XRAY) is currently facing significant legal challenges. The Gross Law Firm has issued a notice to shareholders regarding potential violations of securities laws, inviting those affected to step forward and discuss their options.
Eligibility and Participation
Shareholders who acquired shares of XRAY during the specified class period are encouraged to make contact with legal representatives. This initiative aims to appoint lead plaintiffs who may lead the class action suit, although it's reassured that participation in any recovery doesn’t necessitate becoming a lead plaintiff.
Class Period Details
The class period for this legal matter spans from May 6, 2021, to November 6, 2024. Individuals who purchased shares within this timeframe should be particularly attentive to their rights and the potential for a claim.
Allegations Against Dentsply
The allegations outlined in the complaint highlight several concerns regarding Dentsply's practices. It is claimed that during the class period, the company made materially false and misleading statements and failed to disclose several critical truths about the risks associated with its Byte dental product.
Key Allegations Include:
1. Dentsply reportedly targeted low-income individuals lacking adequate oral hygiene education or dental insurance, leading to a higher risk of complications when using their direct-to-consumer aligners.
2. Employees were allegedly incentivized to push for sales without ensuring patients were proper candidates for the treatment.
3. Complaints regarding patient injuries were reportedly not taken seriously by Dentsply, and the company failed to investigate or inform regulatory bodies like the FDA about these injuries in a timely manner.
4. There has purportedly been a significant increase in injuries reported by patients using Byte products, which Dentsply allegedly concealed from stakeholders.
5. As a result of these allegations, Dentsply is accused of overstating the value and performance of the Byte product line, leading to misleading communications about the company's prospects.
Registration and Next Steps
The deadline for shareholders to register for this class action is January 27, 2025. Investors should be proactive in protecting their rights and are encouraged to register their information as soon as possible. Registration will allow shareholders to utilize a portfolio monitoring service, which will keep them updated on the case's progress.
What to Expect After Registration
Upon registering, shareholders will receive ongoing case updates, ensuring they remain informed every step of the way. It is emphasized that participating in this legal action carries no cost or obligation to individuals.
The Commitment of The Gross Law Firm
The Gross Law Firm is recognized for its commitment to defending the rights of investors. They undertake class action lawsuits with an aim to establish accountability in corporate governance and public trust. Their mission centers on seeking damages for investors who have been affected by deceptive practices and insufficient disclosures.
Company Contact Information
For those who wish to inquire further or seek assistance, The Gross Law Firm can be reached at:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Phone: (646) 453-8903
Frequently Asked Questions
What should I do if I own Dentsply Sirona shares?
If you purchased shares during the class period, contact The Gross Law Firm to explore your rights and consider registering for the class action.
What is the deadline to register for the class action?
The deadline to register is January 27, 2025. Make sure to register before this date to preserve your rights.
Is there a cost to participate in the class action?
No, there is no cost or obligation to participate in this class action lawsuit.
What are the allegations against Dentsply Sirona?
Dentsply is accused of misleading shareholders about the risks associated with its Byte products and failing to disclose significant patient injury reports.
How can I stay updated on the case's progress?
By registering, investors will be enrolled in portfolio monitoring software that provides status updates on the case throughout its duration.
